Skip to main content
Clinical Trials/ITMCTR2000003399
ITMCTR2000003399Not yet recruitingPhase 1

Establishment of a scoring system for predicting postangioplasty restenosis of arteriovenous fistulas and observation on the clinical effect of external treatment with Sanhuang Ointment

Traditional Chinese Medicine Hospital of Hangzhou0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • 1. Maintenance hemodialysis patients with AVF established for more than 3 months;
  • 2. Patients aged >= 18 years;
  • 3. Patients with type I stenosis located near the anastomotic site;
  • 4. Patients who received PTA for the first time;
  • 5. Patients who cooperate with treatment and follow-up and sign informed consent.

Exclusion Criteria

  • 1. Patients with infection, malignant tumor, acute cardiovascular and cerebrovascular events, severe gastrointestinal bleeding or liver disease need to be hospitalized;
  • 2. In the patients with advanced AVF, the internal fistula can not be punctured normally for more than 6 months;
  • 3. Patients with simultaneous central venous catheter;
  • 4. Patients who need to use cutting balloon, medicine coated balloon, stent placement or surgery for PTA failure;
  • 5. Patients with stenosis located at the puncture site of internal fistula and unable to change the puncture site;
  • 6. The subjects were allergic or intolerant to Sanhuang Ointment or fir;
  • 7. The subjects were undergoing hemodialysis and peritoneal dialysis;
  • 8. Subjects are participating in other clinical trials related to vascular access.

Investigators

Sponsor
Traditional Chinese Medicine Hospital of Hangzhou

Similar Trials